PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Rebif
See also: Interferon beta 1a

What is Interferon beta-1a SubQ injection? Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week. Read more...Click to read more below


Reasons Taken

1038 patients in the community are taking or have taken Interferon beta-1a SubQ injection.

Reason # Patients Percentage of patients
Slow my MS progress 911 87%
Other 37 3%
Stiffness/spasticity 14 1%
Fatigue 13 1%
disease-related symptoms 10 <1%
General health 6 <1%
Don't know 5 <1%
Slow my Devic's progress 2 <1%
Pain 2 <1%
Emotional lability 1 <1%
Balance issues 1 <1%
Excessive daytime sleepiness (somnolence) 1 <1%
Brain fog 1 <1%
Anxiety 1 <1%
Depression 1 <1%
Mobility 1 <1%
Treat Parkinson's 1 <1%
MS 1 <1%

Dosages

Based on the patients currently taking Interferon beta-1a SubQ injection.

Top 10 (Show all)

All (Show Top 10)

  0 - day 0 mcg day 0 mg day 0 day 0 - none 0 mcg none 0 mg none 0 - week 0 mcg week 0 mg week 0 week 0.14 mcg week 0.44 mg week 0.5 mcg week 0.5 mg week 0.5 mL week 0.22 mg day 0.25 mcg day 0.25 mg day 1 g week 1 week 0.3 mcg day 0.3 mg day 1.1 week 0.44 mcg week 0.5 mcg week 0.44 mcg day 0.44 mg day 0.44 day 0.5 mcg day 0.5 mg day 0.8 mcg week 0.75 mg day 1 mcg week 3 mcg week 3 mg week 3 week 0.5 mcg day 1 mcg day 1 mg day 1 day 2.2 mcg week 8.8 mcg week 3 mcg week 3 mcg day 3 mg day 4.4 mcg week 15 mcg week 20 mg week 3 mg day 22 mcg week 22 mg week 10 mcg week 30 mcg week 30 mg week 8.8 mg day 33 mg week 10 day 12 mcg week 40 mcg week 44 mcg week 44 mg week 44 week 8 mcg day 60 mg week 22 mcg week 66 mcg week 66 mg week 20 mcg day 20 mg day 22 mcg day 22 mg day 22 day 25 mg day 88 mcg week 30 mcg week 33 mcg week 30 mcg day 112 mcg week 40 mcg week 120 mg week 126 mcg week 18.85708 mcg day 44 mcg week 132 mcg week 132 mg week 132 week 134 mcg week 40 mcg day 40 day 41 mcg day 43 mg day 152 mg week 22 mcg day 44 g day 44 mcg day 44 mg day 44 day 100 mcg week 300 week 0 mcg none 44 mcg day 307.993840123198 mcg week 132 mcg week 395.990760184796 mcg week 138 mcg week 144 mcg week 125 day 132 mcg day 461.990760184796 mcg week 144 mg day 200 mcg week 200 mcg day 200 mg day 923.981520369593 mcg week 923.981520369593 mg week 321 mcg week 300 mg day 200 g day 500 mcg day
  1 Number of Patients: 1 17 Number of Patients: 17 3 Number of Patients: 3 21 Number of Patients: 21 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 33 Number of Patients: 33 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 9 Number of Patients: 9 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 4 Number of Patients: 4 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 31 Number of Patients: 31 17 Number of Patients: 17 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 12 Number of Patients: 12 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 5 Number of Patients: 5 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 118 Number of Patients: 118 51 Number of Patients: 51 16 Number of Patients: 16 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 9 Number of Patients: 9 2 Number of Patients: 2 53 Number of Patients: 53 87 Number of Patients: 87 24 Number of Patients: 24 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 17 Number of Patients: 17 2 Number of Patients: 2 1 Number of Patients: 1 7 Number of Patients: 7 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Interferon beta-1a SubQ injection or how long patients were taking Interferon beta-1a SubQ injection before stopping.

Currently taking Interferon beta-1a SubQ injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
10
25
45
98
99
175

Stopped taking Interferon beta-1a SubQ injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
12
33
39
51
57
90
Why Patients Stopped Taking Interferon beta-1a SubQ injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 154 54% Side effects too severe: 54%
Did not seem to work 84 29% Did not seem to work: 29%
Doctor's advice 62 22% Doctor's advice: 22%
Other 44 15% Other: 15%
Personal research 12 4% Personal research: 4%
Expense 11 4% Expense: 4%
Not indicated 10 3% Not indicated: 3%
Course of treatment ended 5 2% Course of treatment ended: 2%

Patient Reported Evaluations

Results from 49 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 23% 10
Moderate 16% 7
Slight 11% 5
None 11% 5
Can't tell 39% 17

Slow my MS progress

Side-effects (as an overall problem)

Severe 12% 6
Moderate 39% 19
Mild 39% 19
None 10% 5

Top reported side-effects include: Muscle ache, whole body, injection site redness, Headaches

Summary results are based on 49 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 49)

  • jeannadebello23
    Sensation: Moderate
    Overall: Severe
    Cognition: severe
    Vision: moderate
    Speech: moderate
    Swallowing: moderate
    Upper limb: severe
    Walking: severe
    See profile
  • jeannadebello23
  • by jeannadebello23
    Mar 23, 1990
  • EfficacyNone
  • Side-effectsSevere
  • Stiffness/spasticity

  • SAR1965
    Sensation: Moderate
    Overall: Mild
    Cognition: moderate
    Vision: mild
    Speech: mild
    Swallowing: moderate
    Upper limb: moderate
    Walking: moderate
    See profile
  • by SAR1965
    Aug 29, 2008
  • EfficacyCan't tell
  • Side-effectsModerate
  • Slow my MS progress

See all evaluation results for Interferon beta-1a SubQ injection



Back to top